BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Brain Stimulation
- Vol. 11 (5) , 1123-1131
Abstract
No abstract availableKeywords
Funding Information
- Health Research Board (HPF/2010/17, TRA/2007/5)
This publication has 60 references indexed in Scilit:
- Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)Molecular Psychiatry, 2013
- Serum BDNF levels before treatment predict SSRI response in depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disordersJournal of Psychiatry and Neuroscience, 2011
- Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatmentMolecular Psychiatry, 2010
- Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorderEuropean Neuropsychopharmacology, 2010
- Plasma BDNF concentration, Val66Met genetic variant and depression‐related personality traitsGenes, Brain and Behavior, 2010
- Enzyme-Linked Immunosorbent Assay for Detection of Plasmodium falciparum Histidine-Rich Protein 2 in Blood, Plasma, and SerumClinical and Vaccine Immunology, 2008
- Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessationNeuroscience Letters, 2007
- Association Between Obesity and Psychiatric Disorders in the US Adult PopulationArchives of General Psychiatry, 2006
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionCell, 2003